Results 171 to 180 of about 585,966 (213)

Bruton’s Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials

Molecules, 2023
Anna Krupa, Dariusz Pawlak, Justyna Magdalena Hermanowicz   +2 more
exaly  

Inhibitors of brutons tyrosine kinase

2012
HONIGBERG LEE, VERNER ERIK, PAN ZHENGYING, MODY TARAK   +3 more
  +15 more sources

Inhibitors of bruton's tyrosine kinase

2015
DOMINIQUE ROMYR, KONG NORMAN, LOU YAN, LOPEZ-TAPIA FRANCISCO JAVIER, SO SUNG-SAU   +4 more
  +27 more sources

Inhibitors of Bruton's tyrosine kinase

2010
BERTHEL STEVEN, FIROOZNIA FARIBORZ, FISHLOCK DANIEL, HONG JUN-BAE, LOU YAN, LUCAS MATTHEW, OWENS TIMOTHY D, SARMA KESHAB, SWEENEY ZACHARY KEVIN, TAYGERLY JOSHUA PAUL GERGELY   +9 more
  +12 more sources

Bruton's tyrosine kinase inhibitors

2022
LIAO XIBIN, LV YUBIN
openaire   +2 more sources

Emerging small-molecule inhibitors of the Bruton’s tyrosine kinase (BTK): Current development

European Journal of Medicinal Chemistry, 2021
Tian-tai Zhang, Dongmei Wang
exaly  

Pharmacovigilance analysis of cardiac risks associated with Bruton tyrosine kinase inhibitors

Expert Opinion on Drug Safety, 2023
Yang Cao, Xiaofei Ye
exaly  

INHIBITORS OF BRUTON'S TYROSINE KINASE

2014
LOPEZ-TAPIA FRANCISCO JAVIER, SO SUNG-SAU, QIAO QI, DOMINIQUE ROMYR   +3 more
  +14 more sources

Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).

Journal of Experimental Medicine, 1994
Lennart Nilsson, Mauno Vihinen, S P Kwan
exaly  

INHIBITORS OF BRUTON'S TYROSINE KINASE

2008
HONIGBERG LEE, VERNER ERIK J, BUGGY JOSEPH J, LOURY DAVID J, CHEN WEI   +4 more
openaire   +18 more sources